May J, White G H, Yu W, Waugh R, Stephen M S, Sieunarine K, Chaufour X, Harris J P
Department of Surgery, University of Sydney, Australia.
J Endovasc Surg. 1997 May;4(2):147-51. doi: 10.1583/1074-6218(1997)004<0147:EROAAA>2.0.CO;2.
To summarize the results of endovascular abdominal aortic aneurysm (AAA) treatment using several endograft designs over a 4.5-year experience and offer comparisons on the various devices.
From May 1992 to August 1996, 121 AAA patients meeting the criteria for an endoluminal repair were treated with 1 of 5 endograft designs in three configurations. The endografts were implanted in the operating room under fluoroscopic control. Follow-up included contrast-enhanced computed tomography within 10 days of operation, 6 months postoperatively, and annually thereafter.
Endografts were successfully deployed in 106 patients (88%). Fifteen cases were converted to open repair. Six procedure-related deaths occurred within 30 days owing to myocardial infarction (3), combined renal failure and septicemia (2), and multisystem failure (1). There were 36 local/vascular complications (30%) and 18 systemic/remote complications (15%). Of the 121 patients undergoing endoluminal AAA repair, 93 (77%) are currently alive and well with their AAAs excluded from the circulation.
Trends in endoluminal AAA repair and prosthetic design point toward simpler devices and earlier treatment of smaller aneurysms once the long-term outcome of aortic endografting has been determined.
总结在4.5年的经验中使用几种血管内移植物设计治疗腹主动脉瘤(AAA)的结果,并对各种装置进行比较。
1992年5月至1996年8月,121例符合腔内修复标准的AAA患者接受了5种血管内移植物设计中1种的3种构型治疗。血管内移植物在手术室透视控制下植入。随访包括术后10天内、术后6个月以及此后每年进行的增强CT检查。
106例患者(88%)成功植入血管内移植物。15例转为开放修复。30天内发生6例与手术相关的死亡,原因分别为心肌梗死(3例)、合并肾衰竭和败血症(2例)以及多系统衰竭(1例)。有36例局部/血管并发症(30%)和18例全身/远处并发症(15%)。在121例行腔内AAA修复的患者中,93例(77%)目前存活且状况良好,其AAA已被排除在循环系统之外。
一旦确定了主动脉内植入物的长期结果,腔内AAA修复和假体设计的趋势指向更简单的装置以及对较小动脉瘤的早期治疗。